001     139044
005     20240321220538.0
024 7 _ |a 10.1038/mp.2016.18
|2 doi
024 7 _ |a pmid:26976043
|2 pmid
024 7 _ |a pmc:PMC5414086
|2 pmc
024 7 _ |a 1359-4184
|2 ISSN
024 7 _ |a 1476-5578
|2 ISSN
024 7 _ |a altmetric:6191131
|2 altmetric
037 _ _ |a DZNE-2020-05366
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lacour, Andre
|0 P:(DE-2719)2810305
|b 0
|e First author
|u dzne
245 _ _ |a Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
260 _ _ |a London
|c 2017
|b Macmillan
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2016-03-15
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-01-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1591103845_4415
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Few data are available concerning the role of risk markers for Alzheimer's disease (AD) in progression to AD dementia among subjects with mild cognitive impairment (MCI). We therefore investigated the role of well-known AD-associated single-nucleotide polymorphism (SNP) in the progression from MCI to AD dementia. Four independent MCI data sets were included in the analysis: (a) the German study on Aging, Cognition and Dementia in primary care patients (n=853); (b) the German Dementia Competence Network (n=812); (c) the Fundació ACE from Barcelona, Spain (n=1245); and (d) the MCI data set of the Amsterdam Dementia Cohort (n=306). The effects of single markers and combined polygenic scores were measured using Cox proportional hazards models and meta-analyses. The clusterin (CLU) locus was an independent genetic risk factor for MCI to AD progression (CLU rs9331888: hazard ratio (HR)=1.187 (1.054-1.32); P=0.0035). A polygenic score (PGS1) comprising nine established genome-wide AD risk loci predicted a small effect on the risk of MCI to AD progression in APOE-ɛ4 (apolipoprotein E-ɛ4) carriers (HR=1.746 (1.029-2.965); P=0.038). The novel AD loci reported by the International Genomics of Alzheimer's Project were not implicated in MCI to AD dementia progression. SNP-based polygenic risk scores comprising currently available AD genetic markers did not predict MCI to AD progression. We conclude that SNPs in CLU are potential markers for MCI to AD progression.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
542 _ _ |i 2016-03-15
|2 Crossref
|u https://creativecommons.org/licenses/by-nc-nd/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Apolipoprotein E4
|2 NLM Chemicals
650 _ 7 |a Biomarkers
|2 NLM Chemicals
650 _ 7 |a CLU protein, human
|2 NLM Chemicals
650 _ 7 |a Clusterin
|2 NLM Chemicals
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Alzheimer Disease: genetics
|2 MeSH
650 _ 2 |a Apolipoprotein E4: genetics
|2 MeSH
650 _ 2 |a Biomarkers
|2 MeSH
650 _ 2 |a Clusterin: genetics
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: genetics
|2 MeSH
650 _ 2 |a Dementia: genetics
|2 MeSH
650 _ 2 |a Disease Progression
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Follow-Up Studies
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease
|2 MeSH
650 _ 2 |a Genome-Wide Association Study: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide: genetics
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
700 1 _ |a Espinosa, A.
|b 1
700 1 _ |a Louwersheimer, E.
|b 2
700 1 _ |a Heilmann, S.
|b 3
700 1 _ |a Hernández, I.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Wolfsgruber, S.
|0 P:(DE-2719)2810544
|b 5
|u dzne
700 1 _ |a Fernández, V.
|b 6
700 1 _ |a Wagner, H.
|0 P:(DE-2719)2000057
|b 7
|u dzne
700 1 _ |a Rosende-Roca, M.
|b 8
700 1 _ |a Mauleón, A.
|b 9
700 1 _ |a Moreno-Grau, S.
|b 10
700 1 _ |a Vargas, L.
|b 11
700 1 _ |a Pijnenburg, Y. A. L.
|b 12
700 1 _ |a Koene, T.
|b 13
700 1 _ |a Rodríguez-Gómez, O.
|b 14
700 1 _ |a Ortega, G.
|b 15
700 1 _ |a Ruiz, S.
|b 16
700 1 _ |a Holstege, H.
|b 17
700 1 _ |a Sotolongo-Grau, O.
|b 18
700 1 _ |a Kornhuber, J.
|b 19
700 1 _ |a Peters, O.
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Frölich, L.
|b 21
700 1 _ |a Hüll, M.
|b 22
700 1 _ |a Rüther, E.
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Wiltfang, J.
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Scherer, M.
|b 25
700 1 _ |a Riedel-Heller, S.
|b 26
700 1 _ |a Alegret, M.
|b 27
700 1 _ |a Nöthen, M. M.
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Scheltens, P.
|b 29
700 1 _ |a Tárraga, L.
|b 30
700 1 _ |a Jessen, F.
|0 P:(DE-2719)2000032
|b 31
|u dzne
700 1 _ |a Boada, M.
|b 32
700 1 _ |a Maier, W.
|0 P:(DE-2719)2000015
|b 33
|u dzne
700 1 _ |a van der Flier, W. M.
|b 34
700 1 _ |a Becker, T.
|0 P:(DE-2719)2501867
|b 35
|u dzne
700 1 _ |a Ramirez, A.
|0 P:(DE-HGF)0
|b 36
700 1 _ |a Ruiz, A.
|0 P:(DE-HGF)0
|b 37
|e Corresponding author
773 1 8 |a 10.1038/mp.2016.18
|b : Springer Science and Business Media LLC, 2016-03-15
|n 1
|p 153-160
|3 journal-article
|2 Crossref
|t Molecular Psychiatry
|v 22
|y 2016
|x 1359-4184
773 _ _ |a 10.1038/mp.2016.18
|g Vol. 22, no. 1, p. 153 - 160
|0 PERI:(DE-600)1502531-7
|n 1
|q 22:1<153 - 160
|p 153-160
|t Molecular psychiatry
|v 22
|y 2016
|x 1359-4184
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414086
909 C O |o oai:pub.dzne.de:139044
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810305
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810544
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2000057
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2000032
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 33
|6 P:(DE-2719)2000015
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)2501867
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 1
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL PSYCHIATR : 2021
|d 2022-11-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-19
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b MOL PSYCHIATR : 2021
|d 2022-11-19
920 1 _ |0 I:(DE-2719)1013007
|k AG Becker
|l GenomMathematik in der Neuroepidemiologie
|x 0
920 1 _ |0 I:(DE-2719)1011201
|k AG Wagner
|l Neuropsychology
|x 1
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Patient studies cologne
|x 2
920 1 _ |0 I:(DE-2719)7000001
|k U Clinical Researchers - Bonn
|l U Clinical Researchers - Bonn
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013007
980 _ _ |a I:(DE-2719)1011201
980 _ _ |a I:(DE-2719)1011102
980 _ _ |a I:(DE-2719)7000001
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.3233/JAD-122002
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-122002
999 C 5 |a 10.2174/156720510791050858
|9 -- missing cx lookup --
|2 Crossref
|o 10.2174/156720510791050858
999 C 5 |a 10.3233/JAD-2011-0043
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-2011-0043
999 C 5 |a 10.1016/j.jalz.2013.05.1769
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jalz.2013.05.1769
999 C 5 |a 10.1073/pnas.90.5.1977
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.90.5.1977
999 C 5 |a 10.1038/ng.440
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.440
999 C 5 |a 10.1001/jama.2010.574
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/jama.2010.574
999 C 5 |a 10.1038/ng.803
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.803
999 C 5 |a 10.1038/ng.801
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.801
999 C 5 |a 10.1186/gm249
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/gm249
999 C 5 |a 10.1056/NEJMoa1211103
|9 -- missing cx lookup --
|2 Crossref
|o 10.1056/NEJMoa1211103
999 C 5 |a 10.1056/NEJMoa1211851
|9 -- missing cx lookup --
|2 Crossref
|o 10.1056/NEJMoa1211851
999 C 5 |a 10.1038/mp.2013.86
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/mp.2013.86
999 C 5 |a 10.1016/j.neuron.2013.02.026
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuron.2013.02.026
999 C 5 |a 10.1038/ng.2802
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.2802
999 C 5 |a 10.1038/tp.2014.2
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/tp.2014.2
999 C 5 |a 10.1136/jnnp.2010.231555
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/jnnp.2010.231555
999 C 5 |a 10.1371/journal.pone.0016616
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0016616
999 C 5 |a 10.1007/s00702-012-0920-x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00702-012-0920-x
999 C 5 |a 10.1159/000210388
|9 -- missing cx lookup --
|2 Crossref
|o 10.1159/000210388
999 C 5 |a 10.1371/journal.pone.0016852
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0016852
999 C 5 |a 10.3233/JAD-132306
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-132306
999 C 5 |a 10.1038/nature08185
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nature08185
999 C 5 |a 10.1186/1471-2105-13-231
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1471-2105-13-231
999 C 5 |a 10.1001/archneurol.2010.88
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneurol.2010.88
999 C 5 |a 10.1038/tpj.2009.69
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/tpj.2009.69
999 C 5 |a 10.1212/WNL.58.2.209
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.58.2.209
999 C 5 |a 10.1016/j.jagp.2014.03.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jagp.2014.03.008
999 C 5 |a 10.1371/journal.pgen.1004141
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pgen.1004141
999 C 5 |a 10.1016/j.biopsych.2012.05.026
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.biopsych.2012.05.026
999 C 5 |a 10.1001/archgenpsychiatry.2010.78
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archgenpsychiatry.2010.78
999 C 5 |a 10.1001/archneurol.2011.1000
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneurol.2011.1000
999 C 5 |a 10.1016/j.neuroimage.2011.07.056
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2011.07.056
999 C 5 |a 10.1002/ajmg.b.30500
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ajmg.b.30500
999 C 5 |a 10.1371/journal.pone.0006501
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0006501
999 C 5 |a 10.1186/1471-2350-8-S1-S15
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1471-2350-8-S1-S15
999 C 5 |a 10.1001/archneur.60.1.29
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneur.60.1.29
999 C 5 |a 10.1001/archneur.63.7.936
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneur.63.7.936
999 C 5 |a 10.1212/WNL.0b013e3181a2e87d
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0b013e3181a2e87d
999 C 5 |a 10.1093/brain/awv231
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awv231
999 C 5 |a 10.1038/nn.2923
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nn.2923
999 C 5 |a 10.1016/j.brainresrev.2009.05.007
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.brainresrev.2009.05.007
999 C 5 |a 10.1111/jnc.13072
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/jnc.13072
999 C 5 |a 10.1016/S0896-6273(03)00850-X
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0896-6273(03)00850-X
999 C 5 |a 10.1074/jbc.M115.679043
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M115.679043
999 C 5 |a 10.1074/jbc.M115.677286
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M115.677286
999 C 5 |a 10.1016/j.jalz.2014.05.1757
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jalz.2014.05.1757
999 C 5 |a 10.1016/j.biopsych.2012.04.009
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.biopsych.2012.04.009


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21